Administrative Core

行政核心

基本信息

  • 批准号:
    10663865
  • 负责人:
  • 金额:
    $ 48.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-15 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Administrative Core Project Summary The primary goal of the Penn ADRC is to increase research and education on Alzheimer’s disease (AD) and its links to related disorders (ADRD) across the continuum of normal aging to dementia with the goal of identifying the causes of and cures for AD/ADRD. To achieve this goal, the Penn ADRC coordinates research programs, stimulates new research, catalyzes academic research training, provides community education and outreach and fosters the development of novel techniques to individualize diagnosis and treatment for the benefit of all elderly persons and their families. It is the role of the Administrative Core to shepherd and facilitate the activities of the ADRC Cores and to serve as a bridge between the ADRC and national and international efforts in pursuit of these goals. Administrative Core will be involved in a number of different activities that are designed to achieve these broad goals, including fiscal and administrative oversight over the ADRC (Aim 1). The leaders of the ADRC and the ADRC Executive Committee, composed of core leaders and co-leaders, will set priorities and develop plans to achieve ADRC goals. The Administrative Core will choose members of an External Advisory Committee that will be charged with the role of evaluating the progress of the Center and providing recommendations (Aim 2). A variety of forums and opportunities for exchange of ideas and dissemination of data will be supported by the Administrative Core through ADRC sponsored retreats and lecture series (Aim 3). These events will include participation of faculty and trainees, providing an opportunity, particularly for the latter, to present data and receive feedback. Critical to the growth and breadth of AD/ADRC research, a unique Developmental Project program linked to topics at annual retreats will foster transdisciplinary work (Aim 4). The Administrative Core will champion participation of the Penn ADRC in numerous state, national, and international efforts to improve care and treatment of ADRD, as well as provide infrastructure to support the sharing of data and biomaterials (Aim 5). Finally, the core will provide oversight on all NIA and local regulatory and reporting procedures and requirements (Aim 6). Critically, the Administrative Core serves to maintain the “centeredness” of the ADRC by coordinating efforts across the individual cores, by promoting collaborations with other neurodegenerative centers at Penn and beyond, and by promoting activities consistent with our thematic focus around AD heterogeneity. By achieving the above aims, we expect to maintain our highly productive ADRC with the appropriate support to do novel research, to contribute highly and deeply phenotyped individuals to larger data sharing efforts, to grow our diverse and multi-disciplinary faculty by training the next generation of investigators and clinicians, and to educate and empower our region and the nation so as to improve brain health and meet the goals of NAPA.
行政核心项目摘要 宾夕法尼亚州ADRC的主要目标是增加阿尔茨海默病(AD)及其相关疾病的研究和教育。 与正常衰老至痴呆连续体中的相关疾病(ADRD)的联系,目的是确定 AD/ADRD的病因和治疗方法。为了实现这一目标,宾夕法尼亚州ADRC协调研究计划, 鼓励新的研究,促进学术研究培训,提供社区教育和外展 并促进新技术的发展,使诊断和治疗个体化,造福于所有人。 老年人及其家庭。行政核心的作用是引导和促进 活动的ADRC核心,并作为一个桥梁ADRC和国家和国际努力 为了实现这些目标。 行政核心将参与一些旨在实现这些目标的不同活动 广泛的目标,包括对ADRC的财政和行政监督(目标1)。ADRC的领导人 由核心领导人和共同领导人组成的ADRC执行委员会将确定优先事项, 实现ADRC的目标。行政核心将选择外部咨询委员会的成员, 该委员会将负责评估中心的进展情况, 建议(目标2)。提供各种论坛和机会,交流意见和传播 数据将通过ADRC赞助的务虚会和系列讲座(目标3)得到行政核心的支持。 这些活动将包括教师和学员的参与,特别是为 后者是为了提供数据和接收反馈。关键的增长和AD/ADRC研究的广度,一个独特的 与年度务虚会主题相关的发展项目计划将促进跨学科工作(目标4)。的 行政核心将支持宾夕法尼亚州ADRC参与许多州,国家和 国际社会努力改善ADRD的护理和治疗,并提供基础设施, 分享数据和生物材料(目标5)。最后,核心将对所有NIA和当地监管机构提供监督。 报告程序和要求(目标6)。 关键的是,行政核心通过协调努力来保持ADRC的“中心性 通过促进与宾夕法尼亚大学其他神经退行性疾病中心的合作, 超越,并通过促进与我们围绕AD异质性的主题相一致的活动。通过实现 为了实现上述目标,我们期望在适当的支持下保持我们的高效率ADRC, 研究,为更大的数据共享工作贡献高度和深度的表型个体, 多样化和多学科的教师,通过培训下一代的调查人员和临床医生,并 教育我们的区域和国家并赋予其权力,以改善大脑健康并实现国家适应行动方案的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A WOLK其他文献

DAVID A WOLK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A WOLK', 18)}}的其他基金

Clinical Core
临床核心
  • 批准号:
    10461084
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10264227
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10663867
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Penn Alzheimer's Disease Research Center (ADRC)
宾夕法尼亚阿尔茨海默病研究中心 (ADRC)
  • 批准号:
    10461081
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10461082
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Penn Alzheimer's Disease Research Center (ADRC)
宾夕法尼亚阿尔茨海默病研究中心 (ADRC)
  • 批准号:
    10663864
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Penn Alzheimer's Disease Research Center (ADRC)
宾夕法尼亚阿尔茨海默病研究中心 (ADRC)
  • 批准号:
    10264226
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10264228
  • 财政年份:
    2021
  • 资助金额:
    $ 48.98万
  • 项目类别:
Modulators of Medial Temporal Lobe Subregion Structure and Function in Normal and Pathological Aging
正常和病理衰老中内侧颞叶亚区结构和功能的调节器
  • 批准号:
    9229298
  • 财政年份:
    2017
  • 资助金额:
    $ 48.98万
  • 项目类别:
Optimized Arterial Spin Labeling MRI in Mild Cognitive Impairment
优化动脉旋转标记 MRI 在轻度认知障碍中的应用
  • 批准号:
    8372616
  • 财政年份:
    2012
  • 资助金额:
    $ 48.98万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.98万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了